Publications by authors named "Jane M Hook"

Claim this Profile
C
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
Neyssa M Marina, Sigbjørn Smeland, Stefan S Bielack, Mark Bernstein, Gordana Jovic, Jane M Hook

Lancet Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Stefan S Bielack, Sigbjørn Smeland, Jeremy S Whelan, Neyssa Marina, Gordana Jovic, Jane M Hook

J Clin Oncol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance therapy in ovarian cancer.
Saira Khalique, Jane M Hook, Jonathan A Ledermann

Curr Opin Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers in the development of anti-angiogenic therapies for ovarian cancer.
Fharat A Raja, Jane M Hook, Jonathan A Ledermann

Cancer Treat Rev· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: a report from the European Osteosarcoma Intergroup.
Anne McTiernan, Rachel C Jinks, Matthew R Sydes, Barbara Uscinska, Jane M Hook

Eur J Cancer· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis